Home >> Healthcare >> Food & Beverage >>

Global Pulmonary Drugs Market Data Survey Report 2019-2025

Published: Mar-2019 | Format: PDF | HeyReport | Number of pages: 75 | Code: MRS - 430354

Summary
The global Pulmonary Drugs market will reach xxx Million  in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
    AstraZeneca plc
    Bayer AG
    Teva Pharmaceutical Industries Ltd
    Actelion Pharmaceuticals, Inc.
    Boehringer Ingelheim GmbH
    F. Hoffmann-La Roche Ltd.
    Merck & Co., Inc.
    Novartis AG
    GlaxoSmithKline plc
    Sunovion Pharmaceuticals
Major applications as follows:
    Asthma & COPD
    Allergic Rhinitis
    Pulmonary Arterial Hypertension
    Cystic Fibrosis
Major Type as follows:
    Inhaled Corticosteroids (ICS)
    Long-Acting Beta2-Agonists (LABA)
    Antihistamine
    Vasodilators
    Short-Acting Beta2-Agonists (SABA)
    Anticholinergics
    Combination Drugs
    MAbs
    Enzymes
    Antibiotics & Antileukotrienes
Regional market size, production data and export & import:
    Asia-Pacific
    North America
    Europe
    South America
    Middle East & Africa
Table of Contents
1 Global Market Overview
    1.1 Scope of Statistics
        1.1.1 Scope of Products
        1.1.2 Scope of Manufacturers
        1.1.3 Scope of Application
        1.1.4 Scope of Type
        1.1.5 Scope of Regions/Countries
    1.2 Global Market Size
2 Regional Market
    2.1 Regional Production
    2.2 Regional Demand
    2.3 Regional Trade
3 Key Manufacturers
    3.1 AstraZeneca plc
        3.1.1 Company Information
        3.1.2 Product & Services
        3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.1.4 Recent Development
    3.2 Bayer AG
        3.2.1 Company Information
        3.2.2 Product & Services
        3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.2.4 Recent Development
    3.3 Teva Pharmaceutical Industries Ltd
        3.3.1 Company Information
        3.3.2 Product & Services
        3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.3.4 Recent Development
    3.4 Actelion Pharmaceuticals, Inc.
        3.4.1 Company Information
        3.4.2 Product & Services
        3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.4.4 Recent Development
    3.5 Boehringer Ingelheim GmbH
        3.5.1 Company Information
        3.5.2 Product & Services
        3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.5.4 Recent Development
    3.6 F. Hoffmann-La Roche Ltd.
        3.6.1 Company Information
        3.6.2 Product & Services
        3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.6.4 Recent Development
    3.7 Merck & Co., Inc.
        3.7.1 Company Information
        3.7.2 Product & Services
        3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.7.4 Recent Development
    3.8 Novartis AG
        3.8.1 Company Information
        3.8.2 Product & Services
        3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.8.4 Recent Development
    3.9 GlaxoSmithKline plc
        3.9.1 Company Information
        3.9.2 Product & Services
        3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    3.10 Sunovion Pharmaceuticals
        3.10.1 Company Information
        3.10.2 Product & Services
        3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
    4.1 Asthma & COPD
        4.1.1 Overview
        4.1.2 Asthma & COPD Market Size and Forecast
    4.2 Allergic Rhinitis
        4.2.1 Overview
        4.2.2 Allergic Rhinitis Market Size and Forecast
    4.3 Pulmonary Arterial Hypertension
        4.3.1 Overview
        4.3.2 Pulmonary Arterial Hypertension Market Size and Forecast
    4.4 Cystic Fibrosis
        4.4.1 Overview
        4.4.2 Cystic Fibrosis Market Size and Forecast
5 Market by Type
    5.By Inhaled Corticosteroids (ICS)
    5.1 Inhaled Corticosteroids (ICS)
        5.1.1 Overview
        5.1.2 Inhaled Corticosteroids (ICS) Market Size and Forecast
    5.2 Long-Acting Beta2-Agonists (LABA)
        5.2.1 Overview
        5.2.2 Long-Acting Beta2-Agonists (LABA) Market Size and Forecast
    5.3 Antihistamine
        5.3.1 Overview
        5.3.2 Antihistamine Market Size and Forecast
    5.4 Vasodilators
        5.4.1 Overview
        5.4.2 Vasodilators Market Size and Forecast
    5.5 Short-Acting Beta2-Agonists (SABA)
        5.5.1 Overview
        5.5.2 Short-Acting Beta2-Agonists (SABA) Market Size and Forecast
    5.6 Anticholinergics
        5.6.1 Overview
        5.6.2 Anticholinergics Market Size and Forecast
    5.7 Combination Drugs
        5.7.1 Overview
        5.7.2 Combination Drugs Market Size and Forecast
    5.8 MAbs
        5.8.1 Overview
        5.8.2 MAbs Market Size and Forecast
    5.9 Enzymes
        5.9.1 Overview
        5.9.2 Enzymes Market Size and Forecast
    5.10 Antibiotics & Antileukotrienes
        5.10.1 Overview
        5.10.2 Antibiotics & Antileukotrienes Market Size and Forecast
6 Price Overview
    6.1 Price by Manufacturers
    6.2 Price by Application
    6.3 Price by Type
7 Conclusion

                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

Single User | $(USD)1500 View Pricing